OBJECTIVE:: The aim of the study was to evaluate the prevalence and association of subjective symptoms and objective signs of vaginal atrophy (VA). METHODS:: A cross-sectional multicenter study was performed on 913 postmenopausal women consulting 22 gynecological outpatient services. The prevalence of subjective symptoms and objective signs of VA was stratified by years since menopause and related to each other. RESULTS:: In women a year after menopause the prevalence of vaginal dryness was 62% to 67%, of dyspareunia 67.5%, of itching 40%, of burning 48%, and of dysuria 15%. In women years after menopause the prevalence of vaginal dryness and dysuria was higher (85% and 30%, respectively) and that of itching and burning did not exceed 50% a...
Introduction. Vaginal atrophy, which may affect up to 45 % of postmenopausal women, is often associa...
Introduction: The prevalence of menopausal women with confirmed vulvovaginal atrophy (VVA) oscillate...
Objective: we aimed to explore the use of an estro-androgenic symptom questionnaire in women (EASQ-W...
OBJECTIVE:: The aim of the study was to evaluate the prevalence and association of subjective sympto...
Objectives: Prevalence of vulvar-vaginal atrophy (VVA) has been always investigated by phone or webi...
Objectives: To provide data on current management of vaginal atrophy (VA) in a nationwide setting. M...
Objectives: To evaluate the relation between lower urinary tract symptoms (LUTS) and vaginal atrophy...
Objective:The primary aim was to evaluate changes in female sexuality across the menopausal period, ...
AbstractIntroductionVaginal atrophy, which may affect up to 45% of postmenopausal women, is often as...
Background: Age-related vaginal symptoms are a thinning, drying and inflammation of the vagina due t...
Background: Age-related vaginal symptoms are a thinning, drying and inflammation of the vagina due t...
Objectives: To evaluate the association between treatments for vulvovaginal atrophy (VVA) and sympto...
Introduction: The prevalence of menopausal women with confirmed vulvovaginal atrophy (VVA) oscillate...
Objectives: To investigate the management of vaginal atrophy (VA) in a population-based study. Study...
Objective: This subanalysis of the European Vulvovaginal Epidemiology Survey study aimed to assess t...
Introduction. Vaginal atrophy, which may affect up to 45 % of postmenopausal women, is often associa...
Introduction: The prevalence of menopausal women with confirmed vulvovaginal atrophy (VVA) oscillate...
Objective: we aimed to explore the use of an estro-androgenic symptom questionnaire in women (EASQ-W...
OBJECTIVE:: The aim of the study was to evaluate the prevalence and association of subjective sympto...
Objectives: Prevalence of vulvar-vaginal atrophy (VVA) has been always investigated by phone or webi...
Objectives: To provide data on current management of vaginal atrophy (VA) in a nationwide setting. M...
Objectives: To evaluate the relation between lower urinary tract symptoms (LUTS) and vaginal atrophy...
Objective:The primary aim was to evaluate changes in female sexuality across the menopausal period, ...
AbstractIntroductionVaginal atrophy, which may affect up to 45% of postmenopausal women, is often as...
Background: Age-related vaginal symptoms are a thinning, drying and inflammation of the vagina due t...
Background: Age-related vaginal symptoms are a thinning, drying and inflammation of the vagina due t...
Objectives: To evaluate the association between treatments for vulvovaginal atrophy (VVA) and sympto...
Introduction: The prevalence of menopausal women with confirmed vulvovaginal atrophy (VVA) oscillate...
Objectives: To investigate the management of vaginal atrophy (VA) in a population-based study. Study...
Objective: This subanalysis of the European Vulvovaginal Epidemiology Survey study aimed to assess t...
Introduction. Vaginal atrophy, which may affect up to 45 % of postmenopausal women, is often associa...
Introduction: The prevalence of menopausal women with confirmed vulvovaginal atrophy (VVA) oscillate...
Objective: we aimed to explore the use of an estro-androgenic symptom questionnaire in women (EASQ-W...